Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia Podcast Por  arte de portada

Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia

Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia

Escúchala gratis

Ver detalles del espectáculo

In this episode, Contributing Editor Brian Hill, MD, PhD, speaks with Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center in New York. Their conversation focuses on Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia.

Todavía no hay opiniones